Fig. 1.
Effect of EMZFP on blood glucose level in alloxan-induced diabetic rats. Values were presented as mean ± SEM (n=6), $p < 0.001 when compared with normal control; *p < 0.05, **p < 0.01, and ***p < 0.001 when compared with diabetic control. Diabetic animals treated with EMZFP 600 showed a significant reduction in the blood glucose levels (p < 0.01) from14th day onwards.